Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: AI-based adherence support package (including WhatsApp chatbot, IVR calls, digital and manual reminder tools): Participants in the intervention arm will receive an AI-based adherence su
Sponsors
Hamdard Institute of Medical Sciences and Research HIMSR
Eligibility
Inclusion criteria
Inclusion criteria: 1. Non pregnant or non lactating women in reproductive age (18 years or above) with mild to moderate anemia. 2. Women residing in the study area since the last 6 months and are not planning to move out from the study area in the next 6 months. 3. Women having access to mobile phones with internet services. 4. Women willing to participate in the study and giving written informed consent
Exclusion criteria
Exclusion criteria: 1.Women with severe anemia. 2.Women with a history of repeated blood transfusion, hemolytic anemia, chronic diarrhoea, stomach ulcer, heart surgery/prosthetic valves, cancer, tuberculosis, CKD, thalassemia, IBD, Liver disorders, colon cancers. 3.Women currently undergoing medical therapy known to interfere with iron or folic acid absorption/metabolism including tetracyclines, anticoagulants, proton pump inhibitors, antiepileptics, or immunosuppressants etc. will be excluded to ensure outcome validity and participant safety. 4.Women who are already benefiting from existing nutritional supplementation health schemes/on treatment from any medical facility. 5.Women who are unable to understand and provide written informed consent will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Improvement in hemoglobin levels (pre-post comparison) 2.Reduction in prevalence of anemia (intervention vs control) 3.Improved compliance of IFA intake (intervention vs control) Timepoint: 1.Baseline (Week 0) and Endline (Week 24 / 6 months) 2.Baseline (Week 0) and Endline (Week 24 / 6 months) 3.Daily monitoring over 6 months; final assessment at Week 24 (6 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: 1.Continuously monitored throughout the intervention period (Week 0 to Week 24); final assessment at Week 24;Adherence to a full intervention package (counseling, reporting, diary, etc.) Motivational factors and challenges in IFA intake Timepoint: 2.Baseline (Week 0) and Endline (Week 24) | — |
Countries
India
Contacts
Public ContactDr Farzana Islam
Hamdard Institute of Medical Sciences and Research (HIMSR)
Outcome results
None listed